Please Wait
Applying Filters...
menu
    • menu
    Ever Pharma-PSE
    News
    EVER Pharma Gained EU-Approval of Testosterone Enantate

    19 Aug 2024

    // PRESS RELEASE

    EVER Pharma gained EU-Approval for Advanced Cancer Treatment

    16 Apr 2024

    // PRESS RELEASE

    EVER Pharma Announces Approval of Testosterone Undecanoate in the EU

    13 Mar 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Ever Pharma RM

    Contact Supplier

    Website

    33rd NZW-Hamburg

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/i9XL-1ZrZZM
    Menu

    Ever Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/ever-pharma-party-content-39961.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/ever-pharma-party-content-46564.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    EVER Pharma Gained EU-Approval of Testosterone Enantate
    EVER Pharma Gained EU-Approval of Testosterone Enantate

    19 Aug 2024

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-gained-eu-approval-of-testosterone-enantate/

    PRESS RELEASE
    19 Aug 2024
    Share Share
    EVER Pharma gained EU-Approval for Advanced Cancer Treatment
    EVER Pharma gained EU-Approval for Advanced Cancer Treatment

    16 Apr 2024

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-gained-eu-approval-for-advanced-cancer-treatment/

    PRESS RELEASE
    16 Apr 2024
    Share Share
    EVER Pharma Announces Approval of Testosterone Undecanoate in the EU
    EVER Pharma Announces Approval of Testosterone Undecanoate in the EU

    13 Mar 2024

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-announces-approval-of-testosterone-undecanoate-in-the-eu/

    PRESS RELEASE
    13 Mar 2024
    Share Share
    EVER Pharma gains EU Marketing Authorization for Trabectedin
    EVER Pharma gains EU Marketing Authorization for Trabectedin

    22 Jun 2023

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-gains-eu-marketing-authorization-for-trabectedin/

    PRESS RELEASE
    22 Jun 2023
    Share Share
    EVER Pharma Expands Operations with Opening of New Mfg Facility , Germany
    EVER Pharma Expands Operations with Opening of New Mfg Facility , Germany

    10 Mar 2023

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-expands-operations-with-opening-of-new-manufacturing-facility-in-jena-germany/

    PRESS RELEASE
    10 Mar 2023
    Share Share
    EVER Pharma receives EU approval for liquid ready to use Bortezomib formulation
    EVER Pharma receives EU approval for liquid ready to use Bortezomib formulation

    02 Sep 2022

    // PRESS RELEASE

    https://www.everpharma.com/news/ever-pharma-receives-eu-approval-for-a-liquid-ready-to-use-bortezomib-formulation/

    PRESS RELEASE
    02 Sep 2022
    Share Share